Jacobs Levy Equity Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-384,168
| Closed | -$11.2M | – | 1122 |
|
|
2021
Q4 | $11.2M | Buy |
384,168
+86,117
| +29% | +$2.52M | 0.08% | 278 |
|
|
2021
Q3 | $7.59M | Buy |
298,051
+172,956
| +138% | +$4.41M | 0.05% | 356 |
|
|
2021
Q2 | $4.38M | Sell |
125,095
-7,445
| -6% | -$261K | 0.03% | 458 |
|
|
2021
Q1 | $5.4M | Sell |
132,540
-31,980
| -19% | -$1.3M | 0.04% | 406 |
|
|
2020
Q4 | $7.13M | Buy |
164,520
+155,013
| +1,631% | +$6.71M | 0.06% | 330 |
|
|
2020
Q3 | $524K | Buy |
+9,507
| New | +$524K | 0.01% | 783 |
|
|
2016
Q2 | – | Sell |
-28,300
| Closed | -$449K | – | 1255 |
|
|
2016
Q1 | $449K | Buy |
+28,300
| New | +$449K | 0.01% | 750 |
|